Positive News SentimentPositive NewsNASDAQ:RMTI Rockwell Medical (RMTI) Stock Price, News & Analysis $0.62 +0.00 (+0.35%) Closing price 04:00 PM EasternExtended Trading$0.63 +0.01 (+1.31%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rockwell Medical Stock (NASDAQ:RMTI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Rockwell Medical alerts:Sign Up Key Stats Today's Range$0.62▼$0.6550-Day Range$0.62▼$0.9652-Week Range$0.60▼$2.10Volume218,275 shsAverage Volume332,099 shsMarket Capitalization$24.66 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingHold Company Overview Rockwell Medical, Inc. is a Delaware‐domiciled biopharmaceutical company focused on the development and commercialization of therapies for patients with chronic kidney disease (CKD). The company’s mission centers on addressing common complications in CKD—namely iron deficiency and secondary hyperparathyroidism—through innovative treatment approaches designed for dialysis settings. The company’s lead product, TRIFERIC®, is an iron replacement therapy approved by the U.S. Food and Drug Administration for use in hemodialysis patients. TRIFERIC is delivered via dialysate and is intended to replace iron losses that occur during the dialysis process, helping to maintain hemoglobin levels without the need for intravenous iron supplements. In addition to TRIFERIC, Rockwell Medical offers a generic injectable formulation of calcitriol, a form of vitamin D used to manage secondary hyperparathyroidism in CKD patients. Since its founding in 1991, Rockwell Medical has conducted research, clinical development, and regulatory activities primarily in the United States. The company collaborates with specialty distributors and dialysis providers to commercialize its products and is exploring further innovations, including oral formulations of its iron therapy. Rockwell Medical’s operations are led by an experienced management team with backgrounds in nephrology, pharmaceutical development, and health-care commercialization, reflecting its commitment to improving patient outcomes in the CKD community.AI Generated. May Contain Errors. Read More Rockwell Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreRMTI MarketRank™: Rockwell Medical scored higher than 73% of companies evaluated by MarketBeat, and ranked 209th out of 862 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingRockwell Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialRockwell Medical has a consensus price target of $2.00, representing about 220.1% upside from its current price of $0.62.Amount of Analyst CoverageRockwell Medical has only been the subject of 2 research reports in the past 90 days.Read more about Rockwell Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Rockwell Medical are expected to grow in the coming year, from ($0.08) to $0.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Rockwell Medical is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rockwell Medical is -4.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRockwell Medical has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Rockwell Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.99% of the float of Rockwell Medical has been sold short.Short Interest Ratio / Days to CoverRockwell Medical has a short interest ratio ("days to cover") of 1.53, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rockwell Medical has recently decreased by 21.84%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRockwell Medical does not currently pay a dividend.Dividend GrowthRockwell Medical does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentRockwell Medical has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Rockwell Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rockwell Medical insiders have not sold or bought any company stock.Percentage Held by Insiders3.60% of the stock of Rockwell Medical is held by insiders.Percentage Held by Institutions23.31% of the stock of Rockwell Medical is held by institutions.Read more about Rockwell Medical's insider trading history. Receive RMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RMTI Stock News HeadlinesRockwell Medical: Buy Rating Reiterated as Analyst Maintains $2 Price Target on Strengthening Commercial OutlookMay 22, 2026 | tipranks.comRockwell Medical Renews Product Purchase Agreement with aQua DialysisMay 20, 2026 | businesswire.comDo NOT Buy SpaceX – Do This InsteadSpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Harvard MBA, former hedge fund manager, and 30-year Wall Street veteran - calls these the most overhyped, overvalued large-cap stocks ever brought to market. Tilson believes a rare economic event is forming, one he says could reset the financial system in ways most investors aren't prepared for. He's put together a free analysis outlining exactly what he sees and the steps he recommends taking with your money now.June 12 at 1:00 AM | Stansberry Research (Ad)Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage DialysisMay 14, 2026 | businesswire.comRockwell Medical: Profitability Path and Cash-Flow Upside Drive Reiterated Buy Rating and Unchanged $2 Price TargetMay 11, 2026 | tipranks.comRockwell Medical Faces Nasdaq Compliance Challenge, Eyes Reverse SplitMay 8, 2026 | tipranks.comRMTI Q1 2026 Earnings TranscriptMay 8, 2026 | finance.yahoo.comRockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call TranscriptMay 7, 2026 | seekingalpha.comSee More Headlines RMTI Stock Analysis - Frequently Asked Questions How have RMTI shares performed this year? Rockwell Medical's stock was trading at $0.8335 at the beginning of 2026. Since then, RMTI stock has decreased by 25.0% and is now trading at $0.6248. How were Rockwell Medical's earnings last quarter? Rockwell Medical, Inc. (NASDAQ:RMTI) issued its earnings results on Thursday, May, 7th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.03. The business had revenue of $17.34 million for the quarter, compared to analyst estimates of $17.95 million. Rockwell Medical had a negative net margin of 7.98% and a negative trailing twelve-month return on equity of 15.41%. Read the conference call transcript. When did Rockwell Medical's stock split? Rockwell Medical's stock reverse split on the morning of Friday, May 13th 2022.The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split. Who are Rockwell Medical's major shareholders? Rockwell Medical's top institutional shareholders include Renaissance Technologies LLC (1.62%) and Corsair Capital Management L.P. (0.13%). Insiders that own company stock include Larson Family Inve Irrevocable, Mark Strobeck, John G Cooper, Heather Hunter, Timothy Chole, Jesse Neri and Mark H Ravich. View institutional ownership trends. How do I buy shares of Rockwell Medical? Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rockwell Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rockwell Medical investors own include NVIDIA (NVDA), Super Micro Computer (SMCI), Axcelis Technologies (ACLS), Opera (OPRA), ADMA Biologics (ADMA), ASML (ASML) and InterDigital (IDCC). Company Calendar Last Earnings5/07/2026Today6/12/2026AGM 20266/12/2026Next Earnings (Estimated)8/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 11 days, RMTI's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:RMTI CIK1041024 Webwww.rockwellmed.com Phone(248) 432-1362Fax248-960-9119Employees300Year Founded1995Price Target and Rating Average Price Target for Rockwell Medical$2.00 High Price Target$2.00 Low Price Target$2.00 Potential Upside/Downside+220.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.31 million Net Margins-7.98% Pretax Margin-7.98% Return on Equity-15.41% Return on Assets-9.62% Debt Debt-to-Equity Ratio0.23 Current Ratio3.74 Quick Ratio3.43 Sales & Book Value Annual Sales$69.26 million Price / Sales0.36 Cash FlowN/A Price / Cash FlowN/A Book Value$0.94 per share Price / Book0.66Miscellaneous Outstanding Shares39,470,000Free Float38,049,000Market Cap$24.66 million OptionableOptionable Beta1.58 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:RMTI) was last updated on 6/12/2026 by MarketBeat.com Staff. From Our PartnersDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Ha...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThere’s a new type of capitalismThe U.S. government has taken direct equity positions in at least 10 companies - Intel, U.S. Steel, Westinghou...Porter & Company | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredTesla. SolarCity. Twitter. This $4 stock is next.Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...Behind the Markets | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RMTI Stock Alerts